Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume has capped the price of Covid-19 vaccine at $3 per dose for low and middle income countries, including India as part of a new partnership with Gavi, The Vaccine Alliance and the Bill & Melinda Gates Foundation. SII will manufacture and deliver up to 100 million doses of the under development AstraZeneca/Oxford and Novavax COVID-19 vaccines for India and 92 other low- and middle-income countries (LMICs).
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.